128 related articles for article (PubMed ID: 38867265)
21. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
Supali T; Djuardi Y; Christian M; Iskandar E; Alfian R; Maylasari R; Destani Y; Lomiga A; Minggu D; Lew D; Bogus J; Weil GJ; Fischer PU
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009294. PubMed ID: 33780481
[TBL] [Abstract][Full Text] [Related]
22. Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.
Simonsen PE; Derua YA; Magesa SM; Pedersen EM; Stensgaard AS; Malecela MN; Kisinza WN
Parasit Vectors; 2014 Nov; 7():507. PubMed ID: 25387483
[TBL] [Abstract][Full Text] [Related]
23. Albendazole for lymphatic filariasis.
Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
[TBL] [Abstract][Full Text] [Related]
24. Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings.
James A; Coffeng LE; Blok DJ; King JD; de Vlas SJ; Stolk WA
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S131-S137. PubMed ID: 38662696
[TBL] [Abstract][Full Text] [Related]
25. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.
Stolk WA; Prada JM; Smith ME; Kontoroupis P; de Vos AS; Touloupou P; Irvine MA; Brown P; Subramanian S; Kloek M; Michael E; Hollingsworth TD; de Vlas SJ
Clin Infect Dis; 2018 Jun; 66(suppl_4):S260-S266. PubMed ID: 29860286
[TBL] [Abstract][Full Text] [Related]
26. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
27. A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Krentel A; Basker N; Beau de Rochars M; Bogus J; Dilliott D; Direny AN; Dubray C; Fischer PU; Ga AL; Goss CW; Hardy M; Howard C; Jambulingam P; King CL; Laman M; Lemoine JF; Mallya S; Robinson LJ; Samuela J; Schechtman KB; Steer AC; Supali T; Tavul L; Weil GJ
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009002. PubMed ID: 33657090
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and Correlates of Lymphatic Filariasis Infection and Its Morbidity Following Mass Ivermectin and Albendazole Administration in Mkinga District, North-Eastern Tanzania.
Fimbo AM; Minzi OMS; Mmbando BP; Barry A; Nkayamba AF; Mwamwitwa KW; Malishee A; Seth MD; Makunde WH; Gurumurthy P; Lusingu JPA; Kamuhabwa AAR; Aklillu E
J Clin Med; 2020 May; 9(5):. PubMed ID: 32455556
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in Nigeria.
Richards FO; Eigege A; Miri ES; Kal A; Umaru J; Pam D; Rakers LJ; Sambo Y; Danboyi J; Ibrahim B; Adelamo SE; Ogah G; Goshit D; Oyenekan OK; Mathieu E; Withers PC; Saka YA; Jiya J; Hopkins DR
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1346. PubMed ID: 22022627
[TBL] [Abstract][Full Text] [Related]
30. Urban lymphatic filariasis in the city of Tanga, Tanzania, after seven rounds of mass drug administration.
Mwakitalu ME; Malecela MN; Pedersen EM; Mosha FW; Simonsen PE
Acta Trop; 2013 Dec; 128(3):692-700. PubMed ID: 24135628
[TBL] [Abstract][Full Text] [Related]
31. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K; Stolk WA; Basáñez MG; Collyer BS; de Vlas SJ; Diggle PJ; Gass K; Graham M; Hollingsworth TD; King JD; Krentel A; Anderson RM; Coffeng LE
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S93-S100. PubMed ID: 38662701
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
Edi C; Bjerum CM; Ouattara AF; Chhonker YS; Penali LK; Méité A; Koudou BG; Weil GJ; King CL; Murry DJ
PLoS Negl Trop Dis; 2019 May; 13(5):e0007325. PubMed ID: 31107869
[TBL] [Abstract][Full Text] [Related]
33. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
[TBL] [Abstract][Full Text] [Related]
34. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
Minetti C; Tettevi EJ; Mechan F; Prada JM; Idun B; Biritwum NK; Osei-Atweneboana MY; Reimer LJ
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006994. PubMed ID: 30608931
[TBL] [Abstract][Full Text] [Related]
35. Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.
Campillo JT; Awaca-Uvon NP; Missamou F; Tambwe JP; Kuyangisa-Simuna G; Weil GJ; Louya F; Boussinesq M; Pion SDS; Chesnais CB
Clin Infect Dis; 2021 Jul; 73(1):e176-e183. PubMed ID: 32856050
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
[TBL] [Abstract][Full Text] [Related]
37. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
[TBL] [Abstract][Full Text] [Related]
38. Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
Garchitorena A; Raza-Fanomezanjanahary EM; Mioramalala SA; Chesnais CB; Ratsimbasoa CA; Ramarosata H; Bonds MH; Rabenantoandro H
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006780. PubMed ID: 30222758
[TBL] [Abstract][Full Text] [Related]
39. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
[TBL] [Abstract][Full Text] [Related]
40. Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
Mnkai J; Marandu TF; Mhidze J; Urio A; Maganga L; Haule A; Kavishe G; Ntapara E; Chiwerengo N; Clowes P; Horn S; Mosoba M; Lazarus W; Ngenya A; Kalinga A; Debrah A; Rieß F; Saathoff E; Geldmacher C; Hoerauf A; Hoelscher M; Chachage M; Kroidl I
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010044. PubMed ID: 35857778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
